drugset / Trial / NCT01797094
BOTOX® in the Treatment of Upper Facial Lines in Japan
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) for the treatment of upper facial lines (Crow's Feet Lines and Frown Lines).
Timeline
- Start
- 2013-02
- Primary completion
- 2013-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 32 iu | Other |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 44 iu | Other |
Indications
No indication recorded.